Literature DB >> 30169766

Arsenic Alters Exosome Quantity and Cargo to Mediate Stem Cell Recruitment Into a Cancer Stem Cell-Like Phenotype.

Ntube N O Ngalame1, Anthony L Luz1, Ngome Makia1, Erik J Tokar1.   

Abstract

Inorganic arsenic is a human carcinogen that can target the prostate. Accumulating evidence suggests arsenic can disrupt stem cell (SC) dynamics during the carcinogenic process. Previous work demonstrated arsenic-transformed prostate epithelial (CAsE-PE) cells can recruit prostate SCs into rapidly acquiring a cancer SC (CSC) phenotype via the secretion of soluble factors. Exosomes are small, membrane-derived vesicles that contain lipids, RNA, and proteins, and actively contribute to cancer initiation and progression when taken up by target cells. Here we hypothesized that CAsE-PE cells are recruiting SCs to a CSC-like phenotype via exosomal signaling. CAsE-PE cells secreted 700% more exosomes than parental RWPE-1 cells. CAsE-PE exosomes were enriched with oncogenic factors, including oncogenes (KRAS, NRAS, VEFGA, MYB, and EGFR), inflammation-related (cyclooxygenase-2, interleukin 1B (IL1B), IL6, transforming growth factor-β, and tumor necrosis factor-A), and apoptosis-related (CASP7, CASP9, and BCL2) transcripts, and oncogenesis-associated microRNAs. When compared with SCs cultured in exosome-depleted conditioned medium (CM), SCs cultured in CM containing CAsE-PE-derived exosomes showed increased (198%) matrix metalloproteinase activity and underwent an epithelial-to-mesenchymal transition in morphology, suggesting an exosome-mediated transformation. KRAS plays an important role in arsenic carcinogenesis. Although KRAS transcript (>24 000%) and protein (866%) levels were elevated in CAsE-PE exosomes, knock-down of KRAS in these cells only partially mitigated the CSC-like phenotype in cocultured SCs. Collectively, these results suggest arsenic impacts both exosomal quantity and cargo. Exosomal KRAS is only minimally involved in this recruitment, and additional factors (eg, cancer-associated miRNAs) likely also play a role. This work furthers our mechanistic understanding of how arsenic disrupts SC dynamics and influences the tumor microenvironment during carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30169766      PMCID: PMC6111788          DOI: 10.1093/toxsci/kfy176

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  62 in total

1.  Arsenic-specific stem cell selection during malignant transformation.

Authors:  Erik J Tokar; Wei Qu; Jie Liu; Wei Liu; Mukta M Webber; James M Phang; Michael P Waalkes
Journal:  J Natl Cancer Inst       Date:  2010-03-25       Impact factor: 13.506

2.  Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.

Authors:  Ntube N O Ngalame; Ngome L Makia; Michael P Waalkes; Erik J Tokar
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-22       Impact factor: 4.219

3.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET.

Authors:  Héctor Peinado; Maša Alečković; Simon Lavotshkin; Irina Matei; Bruno Costa-Silva; Gema Moreno-Bueno; Marta Hergueta-Redondo; Caitlin Williams; Guillermo García-Santos; Cyrus Ghajar; Ayuko Nitadori-Hoshino; Caitlin Hoffman; Karen Badal; Benjamin A Garcia; Margaret K Callahan; Jianda Yuan; Vilma R Martins; Johan Skog; Rosandra N Kaplan; Mary S Brady; Jedd D Wolchok; Paul B Chapman; Yibin Kang; Jacqueline Bromberg; David Lyden
Journal:  Nat Med       Date:  2012-06       Impact factor: 53.440

4.  Stem/progenitor and intermediate cell types and the origin of human prostate cancer.

Authors:  Erik J Tokar; Brooke B Ancrile; Gerald R Cunha; Mukta M Webber
Journal:  Differentiation       Date:  2005-12       Impact factor: 3.880

5.  Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells.

Authors:  Akira Ooki; Asma Begum; Luigi Marchionni; Christopher J VandenBussche; Shifeng Mao; Max Kates; Mohammad Obaidul Hoque
Journal:  Int J Cancer       Date:  2018-02-14       Impact factor: 7.396

6.  Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.

Authors:  Ntube N O Ngalame; Erik J Tokar; Rachel J Person; Yuanyuan Xu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2014-01-15       Impact factor: 4.849

7.  Chronic exposure of renal stem cells to inorganic arsenic induces a cancer phenotype.

Authors:  Erik J Tokar; Rachel J Person; Yang Sun; Alan O Perantoni; Michael P Waalkes
Journal:  Chem Res Toxicol       Date:  2012-11-19       Impact factor: 3.739

8.  Arsenic exposure transforms human epithelial stem/progenitor cells into a cancer stem-like phenotype.

Authors:  Erik J Tokar; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

Review 9.  Extracellular vesicles: exosomes, microvesicles, and friends.

Authors:  Graça Raposo; Willem Stoorvogel
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

10.  Recruitment of normal stem cells to an oncogenic phenotype by noncontiguous carcinogen-transformed epithelia depends on the transforming carcinogen.

Authors:  Yuanyuan Xu; Erik J Tokar; Rachel J Person; Ruben G Orihuela; Ntube N O Ngalame; Michael P Waalkes
Journal:  Environ Health Perspect       Date:  2013-05-17       Impact factor: 9.031

View more
  10 in total

1.  KRAS-retroviral fusion transcripts and gene amplification in arsenic-transformed, human prostate CAsE-PE cancer cells.

Authors:  B Alex Merrick; Dhiral P Phadke; Meredith A Bostrom; Ruchir R Shah; Garron M Wright; Xinguo Wang; Oksana Gordon; Katherine E Pelch; Scott S Auerbach; Richard S Paules; Michael J DeVito; Michael P Waalkes; Erik J Tokar
Journal:  Toxicol Appl Pharmacol       Date:  2020-04-25       Impact factor: 4.219

Review 2.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

Review 3.  Environmental Exposures and Extracellular Vesicles: Indicators of Systemic Effects and Human Disease.

Authors:  Christina M Eckhardt; Andrea A Baccarelli; Haotian Wu
Journal:  Curr Environ Health Rep       Date:  2022-04-21

Review 4.  Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy.

Authors:  Mengzhen Yu; Yanwen Zhang; Meirong Fang; Shah Jehan; Wenhu Zhou
Journal:  Pharmaceutics       Date:  2022-03-30       Impact factor: 6.525

Review 5.  Environmental exposures, stem cells, and cancer.

Authors:  Tasha Thong; Chanese A Forté; Evan M Hill; Justin A Colacino
Journal:  Pharmacol Ther       Date:  2019-07-31       Impact factor: 12.310

6.  Urinary metals and maternal circulating extracellular vesicle microRNA in the MADRES pregnancy cohort.

Authors:  Caitlin G Howe; Helen B Foley; Shohreh F Farzan; Thomas A Chavez; Mark Johnson; John D Meeker; Theresa M Bastain; Carmen J Marsit; Carrie V Breton
Journal:  Epigenetics       Date:  2021-10-30       Impact factor: 4.861

7.  Cancer Stem Cell-Exosomes, Unexposed Player in Tumorigenicity.

Authors:  Batla S Al-Sowayan; Alaa T Al-Shareeda; Bahauddeen M Alrfaei
Journal:  Front Pharmacol       Date:  2020-03-30       Impact factor: 5.810

Review 8.  Stem Cell-Derived Exosomes and Nanovesicles: Promotion of Cell Proliferation, Migration, and Anti-Senescence for Treatment of Wound Damage and Skin Ageing.

Authors:  Hyeonjin Cha; Seyoung Hong; Ju Hyun Park; Hee Ho Park
Journal:  Pharmaceutics       Date:  2020-11-24       Impact factor: 6.321

9.  Underlying metastasis mechanism and clinical application of exosomal circular RNA in tumors (Review).

Authors:  Xuezhi Wei; Yaxing Shi; Zhijun Dai; Pei Wang; Xin Meng; Bo Yin
Journal:  Int J Oncol       Date:  2021-01-28       Impact factor: 5.650

10.  Nanoplastics and Arsenic Co-Exposures Exacerbate Oncogenic Biomarkers under an In Vitro Long-Term Exposure Scenario.

Authors:  Irene Barguilla; Josefa Domenech; Laura Rubio; Ricard Marcos; Alba Hernández
Journal:  Int J Mol Sci       Date:  2022-03-09       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.